SCHEMBL7222709

SCHEMBL7222709

Cc1ccc(Sc2ccnc(Br)c2N)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
ICAM1 P05362 2/20 0.37
SELE P16581 2/20 0.37
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
HTR1A P08908 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
HTR3A P46098 2/20 0.35
NOS3 P29474 3/20 0.33
NOS2 P35228 3/20 0.33
VCAM1 P19320 1/20 0.33
HTT P42858 1/20 0.32
NOTUM Q6P988 1/20 0.32
KMT2A Q03164 2/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228254 0.76 ALDH1A1 (0.38) ALDH1A1ICAM1SELECYP1A2CYP3A4
SCHEMBL7228451 0.71 ALDH1A1 (0.46) ALDH1A1ICAM1SELEHTTKMT2A
SCHEMBL30015148 0.68
SCHEMBL1970475 0.68
SCHEMBL47860 0.68 ALDH1A1 (0.50) ALDH1A1ICAM1SELECYP1A2CYP3A4
SCHEMBL30832958 0.68 ALDH1A1 (0.50) ALDH1A1ICAM1SELECYP1A2CYP3A4
SCHEMBL20345294 0.66 ALDH1A1 (0.53) ALDH1A1ICAM1SELECYP1A2CYP3A4
SCHEMBL11455389 0.65 CYP3A4 (0.61) ALDH1A1CYP1A2CYP3A4HTR1ACYP2D6
SCHEMBL12792051 0.64 HTR1A (0.54) ALDH1A1ICAM1SELECYP1A2CYP3A4
SCHEMBL11947061 0.64 MAPT (0.49) ALDH1A1ICAM1SELECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583138-B1 Mediators or antagonists of the effects of histamine, leukotriene and the like; heterocyclic ring condensed benzothiazine compounds; inhibit the activation of the tyrosine kinase of 72 kDa EISAI CO., LTD. (JP) 2003-06-24 US disclosed
EP-1057830-A1 HETEROCYCLE-FUSED BENZOTHIAZINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-12-06 EP disclosed